These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15258027

  • 1. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH.
    Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
    [Abstract] [Full Text] [Related]

  • 2. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
    Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT.
    Ophthalmology; 2007 Nov; 114(11):2083-9. PubMed ID: 17459482
    [Abstract] [Full Text] [Related]

  • 3. Results of a prospective study for the treatment of retinoblastoma.
    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.
    Cancer; 2004 Feb 15; 100(4):834-42. PubMed ID: 14770442
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep 15; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 5. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.
    J Clin Oncol; 2013 Apr 10; 31(11):1458-63. PubMed ID: 23460706
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM.
    Arch Ophthalmol; 2001 Jan 10; 119(1):41-8. PubMed ID: 11146725
    [Abstract] [Full Text] [Related]

  • 7. Results of a prospective study for the treatment of unilateral retinoblastoma.
    Chantada GL, Fandiño AC, Guitter MR, Raslawski EC, Dominguez JL, Manzitti J, de Dávila MT, Zubizarreta P, Scopinaro M.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):60-6. PubMed ID: 20486172
    [Abstract] [Full Text] [Related]

  • 8. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
    Cuenca A, Giron F, Castro D, Fandiño A, Guitter M, de Dávila MT, Chantada G.
    Arch Ophthalmol; 2009 Aug 15; 127(8):1006-10. PubMed ID: 19667337
    [Abstract] [Full Text] [Related]

  • 9. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL.
    J Clin Oncol; 2011 Mar 01; 29(7):845-51. PubMed ID: 21282531
    [Abstract] [Full Text] [Related]

  • 10. A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country.
    Suryawanshi P, Ramadwar M, Dikshit R, Kane SV, Kurkure P, Banavali S, Viswanathan S.
    Arch Pathol Lab Med; 2011 Aug 01; 135(8):1017-23. PubMed ID: 21809993
    [Abstract] [Full Text] [Related]

  • 11. Outcome of children with retinoblastoma and isolated choroidal invasion.
    Bosaleh A, Sampor C, Solernou V, Fandiño A, Domínguez J, de Dávila MT, Chantada GL.
    Arch Ophthalmol; 2012 Jun 01; 130(6):724-9. PubMed ID: 22801832
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH.
    Br J Ophthalmol; 2015 Jul 01; 99(7):949-53. PubMed ID: 25583279
    [Abstract] [Full Text] [Related]

  • 13. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.
    Chantada GL, Doz F, Orjuela M, Qaddoumi I, Sitorus RS, Kepak T, Furmanchuk A, Castellanos M, Sharma T, Chevez-Barrios P, Rodriguez-Galindo C, International Retinoblastoma Staging Working Group.
    Pediatr Blood Cancer; 2008 Mar 01; 50(3):692-4. PubMed ID: 18059037
    [Abstract] [Full Text] [Related]

  • 14. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A.
    Arch Ophthalmol; 2011 Nov 01; 129(11):1422-7. PubMed ID: 22084213
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F, Sarıcı AM, Erbek F, Celkan T, Mangan MS, Aydın Ö, Demirkesen C, Pazarlı H.
    Int Ophthalmol; 2018 Feb 01; 38(1):151-156. PubMed ID: 28058667
    [Abstract] [Full Text] [Related]

  • 16. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S, Meel R, Pushker N, Sen S, Bakhshi S, Sreenivas V, Sethi S, Chawla B, Ghose S.
    Pediatr Blood Cancer; 2012 Mar 01; 58(3):356-61. PubMed ID: 21721113
    [Abstract] [Full Text] [Related]

  • 17. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct 01; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 18. Postenucleation adjuvant therapy in high-risk retinoblastoma.
    Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, Shields JA.
    Arch Ophthalmol; 2002 Jul 01; 120(7):923-31. PubMed ID: 12096963
    [Abstract] [Full Text] [Related]

  • 19. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW.
    Br J Ophthalmol; 2015 Oct 01; 99(10):1366-71. PubMed ID: 25873648
    [Abstract] [Full Text] [Related]

  • 20. Treatment of overt extraocular retinoblastoma.
    Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.
    Med Pediatr Oncol; 2003 Mar 01; 40(3):158-61. PubMed ID: 12518344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.